Biochemical screening programme in general practice: a clinical follow-up.

Biochemical screening programme in general practice: a clinical follow-up. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Biochemical screening programme in general practice: a clinical follow-up. Abstract Text:

Biochemical screening programme in general practice: a clinical follow-up. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Biochemical screening programme in general practice: a clinical follow-up. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: British medical journal

VOLUME: 1

Page Numbers: 596-9

Journal Abbreviation: Br Med J

ISSN: 0007-1447

DAY: 13

MONTH: Mar

YEAR: 1971

Biochemical screening programme in general practice: a clinical follow-up. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 372673

Biochemical screening programme in general practice: a clinical follow-up. Keywords Mesh Terms:

KEYWORDS: Uric Acid

MESH TERMS: blood

Chemical & Substance for Abstract: Biochemical screening programme in general practice: a clinical follow-up. Information

Substance Name: Alkaline Phosphatase

Registry Number: EC 3.1.3.1

Grant and Affiliation Information for Biochemical screening programme in general practice: a clinical follow-up.

AFFILIATION:

Country: ENGLAND

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Br Med J

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Biochemical screening programme in general practice: a clinical follow-up Related Publications

• AMPICILLIN IN TREATMENT OF SALMONELLA TYPHI CARRIERS.
• Advances in the treatment of blood diseases.
• Anaesthesia in the dark.
• Bacterial diversity in soil enrichment cultures amended with 2 (2-methyl-4-chlorophenoxy) propionic acid (mecoprop).
• Biochemical screening programme in general practice: a clinical follow-up.
• CLINICAL CHEMISTRY TIME FOR INVESTMENT.
• Can disease be prevented?
• Case of disseminated histoplasmosis.
• Certain haematological aspects of pregnancy.
• Conservation of virally encoded microRNAs in Kaposi sarcoma--associated herpesvirus in primary effusion lymphoma cell lines and in patients with Kaposi sarcoma or multicentric Castleman disease.
• Contamination of hospital disinfectants with Pseudomonas species.
• Diseases of the blood connected with oto-rhino-laryngology.
• Diseases of the reticuloendothelial system and haematology.
• Dyshaemopoiesis from noxious agents.
• Dyshaemopoiesis from nutritional and specific deficiencies.
• Failure to differentiate pulmonary infarction from pneumonia by biochemical tests.
• Industrial action by ASTMS.
• Less invasive autopsy: benefits and limitations of the use of magnetic resonance imaging in the perinatal postmortem.
• Leukaemia. II. Treatment.
• No evidence of sexual transmission of Kaposi's sarcoma herpes virus in a heterosexual South African population.
• OP03.11: Clinically silent extracranial and intracranial hemorrhages-are these a significant pathology or not?
• Out-of-hours services by medical laboratory scientific officers.
• Postmortem MR imaging of the fetal and stillborn central nervous system.
• SNR phase order k-space encoding (SPOKE).
• The physiology of haemopoiesis.
• The science and art of medicine.
• The surgery of the spleen.
• The use and abuse of transfusion.
• Transmission of Kaposi sarcoma-associated herpesvirus between mothers and children in a South African population.
• URINARY EXCRETION OF METABOLITES OF CATECHOLAMINES IN NORMAL INDIVIDUALS AND HYPERTENSIVE PATIENTS.